Drug intelligence / Profile preview

4-oxoretinol

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
01

Overview

**Description:**\n4-Oxoretinol (all-trans) is a naturally occurring retinoid metabolite of all-trans-retinol (vitamin A), in which the hydrogens at position 4 are replaced by an oxo group. It acts as a biologically active signaling molecule and has been shown to function as an antineoplastic agent. Mechanistically, it binds to and activates transcription of the retinoic acid receptors (RARs), but not the retinoid X receptors (RXRs). This activation leads to regulation of gene expression involved in cell differentiation and growth arrest, particularly demonstrated in human promyelocytic leukemia cells and F9 embryonic teratocarcinoma cells. Unlike all-trans-retinoic acid, it does not require conversion to an acid moiety for activity and can induce cellular differentiation directly. It also synergizes with interferon-gamma in promoting cell growth arrest[2][3][5][10].

Other names
all-trans-4-oxoretinolall-trans4-oxoretinolall-trans 4-oxoretinol4-ketoretinol62702-55-015-hydroxyretin-4-one
02

Targets

RARA (Retinoic acid receptor alpha)

Beyond the preview

Go deeper on 4-oxoretinol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-oxoretinol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call